文献速递中医内科中药与中成药合理使用

慢性肾脏病患者调和方剂处方模式的人口横断面研究

Harmonizing Formula Prescription Patterns in Patients With Chronic Kidney Disease: A Population-Based Cross-Sectional Study.
PubMed 文献 · Front Pharmacol · 2021-04-29

本研究基于人群横断面分析24971例慢性肾脏病(CKD)患者,其中5237例(21%)在确诊后接受了调和方剂处方。处方最常用于症状与体征(24.5%)、消化系统疾病(20.67%)和肌肉骨骼系统疾病(12.9%)。年轻、女性、无糖尿病、无高血压、无脑血管病、疾病严重程度较低及使用非甾体抗炎药(NSAIDs)或其他镇痛药与更高的调和方剂处方可能性相关。

要点

  • CKD患者中约21%在确诊后接受调和方剂,主要用于消化与肌肉骨骼症状。
  • 女性、无糖尿病/高血压/脑血管病及低疾病严重程度者更可能使用调和方剂。
  • 使用NSAIDs或其他镇痛药与调和方剂处方可能性升高相关。

核心结论

  • 调和方剂在CKD患者中常用于治疗消化系统和肌肉骨骼系统症状,需进一步研究其对特定CKD患者特征的有效性。

研究设计与样本

  • 基于人群的横断面研究,共纳入24971例CKD患者,其中5237例(21%)在CKD诊断后接受调和方剂处方。

主要发现

  • 调和方剂处方最常见的三类系统疾病/健康问题为症状、体征和未明确情况(24.5%)、消化系统疾病(20.67%)、肌肉骨骼系统疾病(12.9%)。
  • 年轻年龄与调和方剂处方可能性较高相关(调整OR:0.98,95%CI:0.97-0.98)。
  • 女性(OR:1.79,95%CI:1.68-1.91)、无糖尿病(OR:1.20,95%CI:1.06-1.36)、无高血压(OR:1.38,95%CI:1.27-1.50)、无脑血管病(OR:1.34,95%CI:1.14-1.56)与更高的调和方剂处方可能性相关。
  • 疾病严重程度较低(OR:0.85,95%CI:0.83-0.88)、使用NSAIDs(OR:1.65,95%CI:1.54-1.78)、使用其他镇痛药(OR:1.47,95%CI:1.35-1.59)与更高的调和方剂处方可能性相关。

临床怎么用

  • 在CKD患者中,调和方剂处方多针对消化系统与肌肉骨骼系统症状,临床可结合患者年龄、性别、合并症及镇痛药使用情况评估处方倾向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: Harmonizing formulas are associated with beneficial renal outcomes in chronic kidney disease (CKD), but the therapeutic mechanisms are unclear. The study aims to explore the associations of intentions and independent factors with harmonizing formulas prescriptions for patients with CKD. Methods: We conducted a population-based cross-sectional study to explore factors associated with harmonizing formulas prescription. Patients who had been prescribed harmonizing formulas after CKD diagnosis was defined as the using harmonizing formulas group. Disease diagnoses when having harmonizing formula prescriptions and patient characteristics related to these prescriptions were collected. Results: In total, 24,971 patients were enrolled in this analysis, and 5,237 (21%) patients were prescribed harmonizing formulas after CKD diagnosis. The three most frequent systematic diseases and related health problems for which harmonizing formula prescriptions were issued in CKD were symptoms, signs, and ill-defined conditions (24.5%), diseases of the digestive system (20.67%), and diseases of the musculoskeletal system (12.9%). Higher likelihoods of harmonizing formula prescriptions were associated with young age (adjusted odds ratio: 0.98, 95% confidence interval: 0.97-0.98), female sex (1.79, 1.68-1.91), no diabetes (1.20, 1.06-1.36), no hypertension (1.38, 1.27-1.50), no cerebrovascular disease (1.34, 1.14-1.56), less disease severity (0.85, 0.83-0.88), using nonsteroidal anti-inflammatory drugs (NSAIDs) (1.65, 1.54-1.78), and using analgesic drugs other than NSAIDs (1.47, 1.35-1.59). Conclusion: Harmonizing formulas are commonly used for treating symptoms of the digestive and musculoskeletal systems in CKD cases. Further research on harmonizing formula effectiveness with regard to particular characteristics of CKD patients is warranted.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Lin HL, Lin MY, Tsai CH, et al. Harmonizing Formula Prescription Patterns in Patients With Chronic Kidney Disease: A Population-Based Cross-Sectional Study. Front Pharmacol. 2021. PMID: 33995002. doi:10.3389/fphar.2021.573145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。